Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF

Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference

Rana Assaly on LinkedIn: #pelvipharm #erectile #preclinical

François Briand på LinkedIn: Physiogenex - effects of TRF

François Briand på LinkedIn: #tlm22 #obesity #nash #heartfailure

François Briand en LinkedIn: #ksns #nash #obesity #drugdevelopment

Physiogenex to attend The Keystone Symposia Immunometabolism

Elafibranor improves diet-induced nonalcoholic steatohepatitis

Obesity-Related Heart Failure With a Preserved Ejection Fraction

Natália Breyner - Scientist/Project Manager/R&D at Physiogenex

Full article: Heart failure with preserved ejection fraction

Natália Breyner sur LinkedIn : I am glad to announce that

NAD+ Repletion Reverses Heart Failure With Preserved Ejection

Cellular and molecular pathobiology of heart failure with